Gynecologic Cancer
News
FDA grants accelerated approval for new treatment of female cancers
Eligible patients for mirvetuximab soravtansine include those with folate receptor alpha, chemo resistant ovarian, fallopian and peritoneal...
From the Journals
Analysis affirms that giving birth protects against endometrial cancer
Researchers found that more live births has a protective effect on the risk of endometrial cancer, even when accounting for other risk factors.
Latest News
Promising new antibiotic emerges for treating UTIs
It would be the first new treatment in 20 years for UTIs, which affect more than half of women at least sometime in their lives.
Latest News
Study uncovers two molecular subgroups of cervical cancer
Patients with so-called C2 tumors were more than twice as likely to die from their cervical cancer at any point during the follow-up period - up...
Feature
Hair straighteners’ risk too small for docs to advise against their use
Primary care doctors are unlikely to address the increased risk of uterine cancer in women who frequently use hair straighteners that a new study...
Gynecologic Oncology Consult
Germline genetic testing: Why it matters and where we are failing
Cancer and medical societies recommend universal genetic counseling and testing for patients diagnosed with epithelial ovarian cancer.
Latest News
HPV infection in pregnancy higher among women living with HIV
"Women living with HIV have a sixfold increased rate of developing cervical cancer compared to women without HIV."
Gynecologic Oncology Consult
The role of repeat uterine curettage in postmolar gestational trophoblastic neoplasia
Second uterine evacuation for treatment of nonmetastatic, low-risk postmolar GTN is a reasonable treatment option and one that should be...
From the Journals
Early trial supports hypofractionated radiotherapy in uterine cancer
Early toxicity results are encouraging, but long-term efficacy and safety remain unknown.
From the Journals
Shortened radiotherapy for endometrial cancer looks safe, questions remain
Early toxicity results are encouraging, but long-term efficacy and safety remain unknown.
Feature
In America, cancer patients endure debt on top of disease
“It’s crippling. Even if someone survives the cancer, they often can’t shake the debt.”